OCS

Conviction 4HealthcareScan · Thu, Jun 25, 2026

OCS$11.71+1.30%

ResistanceSupportVol 14

Vol MA14 721.7K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Oculis Holding AGBiotechnologywww.oculis.com ↗

Price11.71

Change+1.30%

Gap+1.25%

Rel volume0.32×

Avg volume1.3M

Avg $ vol18.03M

SMA 2013.12

SMA 5022.50

SMA 20022.71

Price vs 50-47.97%

Price vs 200-48.44%

MA stackbearish

50/200 crossdeath · 0d

Supertrenddown · 15.18

RSI (14)27

MACD hist0.46

MACD crossbull · 3d

Stoch %K / %D72 / 52

ADX (14)46

+DI / −DI13 / 36

RSI divergence—

MACD divergence—

ATR %+11.11%

ADR %9.35%

52w high32.65

52w low10.71

From 52w high-64.13%

Above 52w low+9.34%

New 52w highNo

SqueezeOff

Bollinger width139.28%

%B0.42

Donchian pos6.12%

Donchian high29.98

Donchian low10.52

AVWAP (52w high)16.94

vs AVWAP high-30.85%

AVWAP (52w low)11.30

vs AVWAP low+3.66%

OBV trendDown

Chaikin MF (20)-0.35

Today vs 20d0.32×

Avg vol (14d)721.7K

Avg vol (20d)1.3M

Avg $ vol (20d)18.03M

Market cap669.7M

RS 3m (vs SPY)-65.11%

RS 6m (vs SPY)-53.34%

RS line new highNo

Trend template1/8

Technical rank7.6

1 week+3.63%

1 month-60.88%

3 months-53.16%

6 months-42.46%

1 year-40.71%

YTD-41.45%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target38.30

Target upside227.07%

Analyst ratingBuy

Institutional29.68%

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out57.98M

Employees60

ListedFri, Mar 3, 2023

Free float34.79M

Float %66.4%

Short interest651.25K

Days to cover1.0d

Short volume52.3%

Squeeze score17 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.63 vs −$0.49

Last surprise-28.6% miss

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank7.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance32.87

Support10.70

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in OCS

All disclosures →

No recent disclosed trades by Congress in OCS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OCS

No recent insider (Form 4) filings in OCS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in OCS · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.